SRX

Welcome to the Brand page for “SRX”, which is offered here for The mark consists of the stylized letters srx in white on a blue grey oval background that fades from darker to lighter from the top to the bottom.;pharmaceutical products and substances for treating neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes;the color(s) blue grey and white is/are claimed as a feature of the mark.;pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; biological research; clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; scientific research and analysis in the field of medical reagents; providing research and development of technology in the field of neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; technical research in the field of neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; technical project studies in the field of neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; scientific laboratory services;.

Its status is currently believed to be active. Its class is unavailable. “SRX” is believed to be currently owned by “SyneuRx International Corp.”